{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35974108", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "02"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1038/s41423-022-00876-z"], "Journal": {"ISSN": "2042-0226", "JournalIssue": {"Volume": "19", "Issue": "11", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "Cellular & molecular immunology", "ISOAbbreviation": "Cell Mol Immunol"}, "ArticleTitle": "Novel insights into the role of anti-inflammatory IL-38 in immunity against infection.", "Pagination": {"StartPage": "1322", "EndPage": "1324", "MedlinePgn": "1322-1324"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing, China."}], "LastName": "Gao", "ForeName": "Xun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing, China."}], "LastName": "Wu", "ForeName": "Guoqiu", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Tsang", "ForeName": "Miranda Sin-Man", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Huang", "ForeName": "Danqi", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China."}], "LastName": "Lam", "ForeName": "Christopher Wai-Kei", "Initials": "CW"}, {"Identifier": ["0000-0002-5637-8331"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China. ck-wong@cuhk.edu.hk."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China. ck-wong@cuhk.edu.hk."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R and D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. ck-wong@cuhk.edu.hk."}], "LastName": "Wong", "ForeName": "Chun Kwok", "Initials": "CK"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Cell Mol Immunol", "NlmUniqueID": "101242872", "ISSNLinking": "1672-7681"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "82115-62-6", "NameOfSubstance": "Interferon-gamma"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Interferon-gamma"}, {"QualifierName": [], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Immunity, Innate"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mora J, Schlemmer A, Wittig I, Richter F, Putyrski M, Frank AC, et al. Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. J Mol Cell Biol. 2016;8:426\u201338. doi: 10.1093/jmcb/mjw006.", "ArticleIdList": ["10.1093/jmcb/mjw006", "26892022"]}, {"Citation": "van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, Netea MG, et al. Il-38 binds to the il-36 receptor and has biological effects on immune cells similar to il-36 receptor antagonist. Proc Natl Acad Sci USA. 2012;109:3001\u20135. doi: 10.1073/pnas.1121534109.", "ArticleIdList": ["10.1073/pnas.1121534109", "PMC3286950", "22315422"]}, {"Citation": "Sun X, Hou T, Cheung E, Iu TN, Tam VW, Chu IM, et al. Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma. Cell Mol Immunol. 2020;17:631\u201346. doi: 10.1038/s41423-019-0300-7.", "ArticleIdList": ["10.1038/s41423-019-0300-7", "PMC7264207", "31645649"]}, {"Citation": "Gao X, Chan P, Lui G, Hui D, Chu IM, Sun X, et al. Interleukin-38 ameliorates poly(i:C) induced lung inflammation: Therapeutic implications in respiratory viral infections. Cell Death Dis. 2021;12:53. doi: 10.1038/s41419-020-03283-2.", "ArticleIdList": ["10.1038/s41419-020-03283-2", "PMC7790341", "33414457"]}, {"Citation": "Al-Bassam WW, Al-Karaawi IA, Sharquie IK, Ad\u2019hiah AH. Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019. J Med Virol. 2022. 10.1002/jmv.27762. Online ahead of print.", "ArticleIdList": ["PMC9088597", "35388498"]}, {"Citation": "Alaaraji SFT. Exploration of the relationship between interleukins 17, 37 and 38 with vitamin e in iraqi men with chb. Phys: Conf Ser. 2019;1294:052047."}, {"Citation": "Wang HJ, Jiang YF, Wang XR, Zhang ML, Gao PJ. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis b. World J Gastroenterol. 2016;22:4529\u201337. doi: 10.3748/wjg.v22.i18.4529.", "ArticleIdList": ["10.3748/wjg.v22.i18.4529", "PMC4858634", "27182162"]}, {"Citation": "Fazeli P, Saeidnia M, Erfani M, Kalani M. An overview of the biological and multifunctional roles of il-38 in different infectious diseases and covid-19. Immunol Res. 2022:1\u20139. 10.1007/s12026-022-09275-y. Online ahead of print.", "ArticleIdList": ["PMC8902906", "35260945"]}, {"Citation": "Gresnigt MS, R\u00f6sler B, Jacobs CW, Becker KL, Joosten LA, van der Meer JW, et al. The il-36 receptor pathway regulates aspergillus fumigatus-induced th1 and th17 responses. Eur J Immunol. 2013;43:416\u201326. doi: 10.1002/eji.201242711.", "ArticleIdList": ["10.1002/eji.201242711", "23147407"]}, {"Citation": "Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for c-reactive protein levels. Circulation. 2011;123:731\u20138. doi: 10.1161/CIRCULATIONAHA.110.948570.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.110.948570", "PMC3147232", "21300955"]}, {"Citation": "Xu F, Lin S, Yan X, Wang C, Tu H, Yin Y, et al. Interleukin 38 protects against lethal sepsis. J Infect Dis. 2018;218:1175\u201384. doi: 10.1093/infdis/jiy289.", "ArticleIdList": ["10.1093/infdis/jiy289", "29762676"]}, {"Citation": "Ge Y, Huang M, Wu Y, Dong N, Yao YM. Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of cd4(+) cd25(+) regulatory t cells. J Cell Mol Med. 2020;24:2027\u201339. doi: 10.1111/jcmm.14902.", "ArticleIdList": ["10.1111/jcmm.14902", "PMC6991686", "31880383"]}, {"Citation": "Ge Y, Chen J, Hu Y, Chen X, Huang M. Il-38 alleviates inflammation in sepsis in mice by inhibiting macrophage apoptosis and activation of the nlrp3 inflammasome. Mediators Inflamm. 2021;2021:6370911. doi: 10.1155/2021/6370911.", "ArticleIdList": ["10.1155/2021/6370911", "PMC8709774", "34955683"]}, {"Citation": "Chai YS, Lin SH, Zhang M, Deng L, Chen Y, Xie K, et al. Il-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates th17 differentiation in vivo. Clin Immunol. 2020;210:108315. doi: 10.1016/j.clim.2019.108315.", "ArticleIdList": ["10.1016/j.clim.2019.108315", "31756565"]}, {"Citation": "de Graaf DM, Teufel LU, van de Veerdonk FL, Joosten L, Netea MG, Dinarello CA, et al. Il-38 prevents induction of trained immunity by inhibition of mtor signaling. J Leukoc Biol. 2021;110:907\u201315. doi: 10.1002/JLB.3A0220-143RRR.", "ArticleIdList": ["10.1002/JLB.3A0220-143RRR", "PMC8380748", "33620105"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "21"}, {"Year": "2022", "Month": "4", "Day": "23"}, {"Year": "2022", "Month": "8", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "16", "Hour": "23", "Minute": "27"}, {"Year": "2023", "Month": "11", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35974108", "PMC9379218", "10.1038/s41423-022-00876-z", "10.1038/s41423-022-00876-z"]}}], "PubmedBookArticle": []}